Abstract
Spinal cord stimulation (SCS) has been widely noted as a treatment for ischemic pain secondary to peripheral vascular disease, but evidence in the vasculitis disease state is lacking. In this paper we present two cases that exemplify the potential of SCS in this unique population. Two case studies involving patients with the conditions noted including initial findings, treatment protocol, and results documented throughout the treatment regimen. A comprehensive review of the critical literature also was performed. Both patients showed marked improvement with SCS. Pain scores improved dramatically, with a major improvement in disease symptom and quality of life. Based on literature and our results, SCS is an effective and safe therapy for patients with therapeutically refractory vasculitis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
